Stubborn Fat Protocol

The Stubborn Fat Protocol combines AOD-9604 with 5-Amino-1MQ to address fat deposits that resist conventional diet and exercise interventions. AOD-9604, the modified GH fragment (177-191), directly stimulates lipolysis in adipose tissue by activating beta-3 adrenergic receptor pathways and inhibiting lipogenesis without the metabolic side effects of full-length growth hormone. Its mechanism specifically targets adipocytes in a way that mimics GH''s fat-mobilizing action while avoiding its glucose-raising and IGF-1-stimulating properties. 5-Amino-1MQ is a small molecule inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme that is overexpressed in adipose tissue of obese individuals. NNMT regulates cellular energy expenditure through the NAD+ salvage pathway — when NNMT is overactive, it depletes SAM (S-adenosylmethionine) and reduces NAD+ availability, effectively slowing cellular metabolism. By inhibiting NNMT, 5-Amino-1MQ increases intracellular NAD+ and SAM levels, revving up metabolic rate within fat cells and promoting their energy expenditure rather than energy storage. The combination addresses stubborn fat through two independent mechanisms: AOD-9604 directly stimulates fat cell lipolysis (breaking triglycerides into free fatty acids for oxidation), while 5-Amino-1MQ increases the metabolic rate of adipocytes so they burn more energy. Stubborn fat areas (lower abdomen, love handles, thighs) typically have higher alpha-2 adrenergic receptor density and lower blood flow, making them resistant to catecholamine-driven fat mobilization. This dual approach bypasses some of these limitations. The protocol is classified as beginner-friendly due to its simplicity (one injection, one oral dose daily), though users should understand that both compounds require further human research.